Western Blot: AMOT Antibody [H00154796-B01P] - Analysis of AMOT expression in transfected 293T cell line by AMOT polyclonal antibody. Lane 1: AMOT transfected lysate(74.25 KDa). Lane 2: Non-transfected lysate.
Western Blot: AMOT Antibody [H00154796-B01P] - analysis of AMOT expression in transfected 293T cell line by AMOT purified MaxPab polyclonal antibody (B01P). Lane 1: AMOT transfected lysate (72.50 KDa). Lane 2: ...read more
Western Blot: AMOT Antibody [H00154796-B01P] - AMOT MaxPab polyclonal antibody. Western Blot analysis of AMOT expression in rat brain.
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
PBS (pH 7.4)
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for AMOT Antibody
angiomotin p80 isoform
KIAA1071angiomotin p130 isoform
This gene belongs to the motin family of angiostatin binding proteins characterized by conserved coiled-coil domains and C-terminal PDZ binding motifs. The encoded protein is expressed predominantly in endothelial cells of capillaries as well as larger vessels of the placenta where it may mediate the inhibitory effect of angiostatin on tube formation and the migration of endothelial cells toward growth factors during the formation of new blood vessels. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
Review this Product
Be the first to review our AMOT Antibody and receive a gift card or discount.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.